Download PDF
Am J Perinatol
DOI: 10.1055/a-2620-7831
Original Article

Surgical Bundle to Reduce Infectious Morbidity after Cesarean Delivery in Individuals with Morbid Obesity

Martina Benuzzi 
1   EVMS Department of Obstetrics and Gynecology, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia
2   Obstetrics and Gynecology Unit, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy
,
Misa Hayasaka
1   EVMS Department of Obstetrics and Gynecology, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia
,
Alyssa Savelli 
1   EVMS Department of Obstetrics and Gynecology, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia
,
George Saade
1   EVMS Department of Obstetrics and Gynecology, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia
,
Emily Peters
1   EVMS Department of Obstetrics and Gynecology, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia
,
Tetsuya Kawakita 
1   EVMS Department of Obstetrics and Gynecology, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia
› Author Affiliations
Funding This study was supported by the Eastern Virginia Medical School Junior Clinical Investigator Program (grant no.: VHS 241231).
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objective

This study aimed to evaluate whether the implementation of a surgical bundle reduces surgical site infections (SSI), hospital readmission rates, and emergency department (ED) visits within 6 weeks in individuals with a body mass index (BMI) of 40 kg/m2 or greater after cesarean delivery.

Study Design

This was a retrospective study including individuals with morbid obesity undergoing cesarean delivery at 23 weeks of gestation or greater. The preintervention period spanned from January 2017 to December 2020. The postintervention period extended from January 2021 to April 2023. The surgical bundle included standard preprocedure prophylactic antibiotics and a 48-hour course of oral cephalexin and metronidazole. The primary outcome was SSIs while secondary outcomes included hospital readmission or ED visits within 6 weeks postpartum or wound complications (dehiscence, seroma, or hematoma). Adjusted relative risks (aRR) with 95% confidence intervals (95% CI) were calculated using modified Poisson regression, adjusting for potential confounders.

Results

Of 2,105 pregnancies, 1,308 (62.1%) underwent cesarean in the preintervention period and 797 (37.9%) in the postintervention period. Compared to the preintervention period, the postintervention period had increased use of azithromycin (30.6 vs. 35.9%; p = 0.012), cephalexin (1.8 vs. 52.8%; p < 0.001), and metronidazole (3.1 vs. 60.4%; p < 0.001). However, compared to the preintervention period, the postintervention period had a similar risk of SSIs (6.6 vs. 5.9%; aRR: 0.92; 95% CI: 0.66–1.28), readmission or ED visits (19.8 vs. 19.8%; aRR: 0.94; 95% CI: 0.80–1.11), and wound complications (4.7 vs. 6.4%; aRR: 1.37; 95% CI: 0.96–1.96). In individuals with labor or ruptured membranes, the postintervention period had increased use of azithromycin (74.9 vs. 82.3%; p = 0.022), cephalexin (2.5 vs. 56.1%; p < 0.001), and metronidazole (4.3 vs. 63.8%; p < 0.001). In this subgroup, outcomes remained insignificant.

Conclusion

A morbid obesity surgical bundle increased antibiotic use but did not reduce SSIs, hospital readmission, ED department visits, and wound complications.

Key Points

  • A surgical bundle for individuals with morbid obesity increased the use of postoperative antibiotics.

  • The surgical bundle did not significantly reduce SSIs.

  • The surgical bundle did not significantly reduce hospital readmissions and ED visits.

Keywords

surgical bundle - morbid obesity - infection - readmission - emergency department

Note

This paper was presented at the 45th annual meeting—the pregnancy meeting of the Society for Maternal–Fetal Medicine, from January 27 to February 1, 2025.


Supplementary Material



Publication History

Received: 30 April 2025

Accepted: 23 May 2025

Accepted Manuscript online:
26 May 2025

Article published online:
10 June 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2017. Natl Vital Stat Rep 2018; 67 (08) 1-50
    Search in Google Scholar
  • 2 Burrows LJ, Meyn LA, Weber AM. Maternal morbidity associated with vaginal versus cesarean delivery. Obstet Gynecol 2004; 103 (5 Pt 1): 907-912
    Search in Google Scholar
  • 3 Blumenfeld YJ, El-Sayed YY, Lyell DJ, Nelson LM, Butwick AJ. Risk Factors for prolonged postpartum length of stay following cesarean delivery. Am J Perinatol 2015; 32 (09) 825-832
    Search in Google Scholar
  • 4 Tita AT, Szychowski JM, Boggess K. et al; C/SOAP Trial Consortium. Adjunctive azithromycin prophylaxis for cesarean delivery. N Engl J Med 2016; 375 (13) 1231-1241
    Search in Google Scholar
  • 5 Haas DM, Pazouki F, Smith RR. et al. Vaginal cleansing before cesarean delivery to reduce postoperative infectious morbidity: a randomized, controlled trial. Am J Obstet Gynecol 2010; 202 (03) 310.e1-310.e6
    Search in Google Scholar
  • 6 Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol 2003; 101 (02) 289-296
    Search in Google Scholar
  • 7 Costantine MM, Rahman M, Ghulmiyah L. et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol 2008; 199 (03) 301.e1-301.e6
    Search in Google Scholar
  • 8 Mackeen AD, Khalifeh A, Fleisher J. et al. Suture compared with staple skin closure after cesarean delivery: a randomized controlled trial. Obstet Gynecol 2014; 123 (06) 1169-1175
    Search in Google Scholar
  • 9 Peleg D, Eberstark E, Warsof SL, Cohen N, Ben Shachar I. Early wound dressing removal after scheduled cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol 2016; 215 (03) 388.e1-388.e5
    Search in Google Scholar
  • 10 Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ. Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol 2008; 29 (06) 477-484 , discussion 485–486
    Search in Google Scholar
  • 11 Smid MC, Kearney MS, Stamilio DM. Extreme obesity and postcesarean wound complications in the maternal-fetal medicine unit cesarean registry. Am J Perinatol 2015; 32 (14) 1336-1341
    Search in Google Scholar
  • 12 Stamilio DM, Scifres CM. Extreme obesity and postcesarean maternal complications. Obstet Gynecol 2014; 124 (2 Pt 1): 227-232
    Search in Google Scholar
  • 13 Gillespie BM, Ellwood D, Thalib L. et al. Incidence and risk factors for surgical wound complications in women with body mass index >30 kg/m2 following cesarean delivery: a secondary analysis. AJOG Glob Rep 2022; 2 (03) 100069
    Search in Google Scholar
  • 14 Kawakita T, Landy HJ. Surgical site infections after cesarean delivery: epidemiology, prevention and treatment. Matern Health Neonatol Perinatol 2017; 3: 12
    Search in Google Scholar
  • 15 Kawakita T, Iqbal SN, Landy HJ, Huang JC, Fries M. Reducing cesarean delivery surgical site infections: a resident-driven quality initiative. Obstet Gynecol 2019; 133 (02) 282-288
    Search in Google Scholar
  • 16 Valent AM, DeArmond C, Houston JM. et al. Effect of post-cesarean delivery oral cephalexin and metronidazole on surgical site infection among obese women: a randomized clinical trial. JAMA 2017; 318 (11) 1026-1034
    Search in Google Scholar
  • 17 Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (standards for quality improvement reporting excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 2016; 25 (12) 986-992
    Search in Google Scholar
  • 18 Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 1999; 27 (02) 97-132 , quiz 133–134, discussion 96
    Search in Google Scholar
  • 19 Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159 (07) 702-706
    Search in Google Scholar
  • 20 Li L, Cui H. The risk factors and care measures of surgical site infection after cesarean section in China: a retrospective analysis. BMC Surg 2021; 21 (01) 248
    Search in Google Scholar
  • 21 Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts. BMC Med Res Methodol 2017; 17 (01) 162
    Search in Google Scholar
  • 22 Carter EB, Temming LA, Fowler S. et al. Evidence-based bundles and cesarean delivery surgical site infections: a systematic review and meta-analysis. Obstet Gynecol 2017; 130 (04) 735-746
    Search in Google Scholar
  • 23 Bolte M, Knapman B, Leibenson L, Ball J, Giles M. Reducing surgical site infections post-caesarean section in an Australian hospital, using a bundled care approach. Infect Dis Health 2020; 25 (03) 158-167
    Search in Google Scholar
  • 24 Sood N, Lee RE, To JK. et al. Decreased incidence of cesarean surgical site infection rate with hospital-wide perioperative bundle. Birth 2022; 49 (01) 141-146
    Search in Google Scholar
  • 25 Scholz R, Smith BA, Adams MG. et al. A multifaceted surgical site infection prevention bundle for cesarean delivery. Am J Perinatol 2021; 38 (07) 690-697
    Search in Google Scholar
  • 26 Davidson C, Enns J, Dempster C, Lundeen S, Eppes C. Impact of a surgical site infection bundle on cesarean delivery infection rates. Am J Infect Control 2020; 48 (05) 555-559
    Search in Google Scholar
  • 27 Erritty M, Hale J, Thomas J. et al. Reduction of adverse outcomes from cesarean section by surgical-site infection prevention care bundles in maternity. Int J Gynaecol Obstet 2023; 161 (03) 963-968
    Search in Google Scholar
  • 28 Farid Mojtahedi M, Sepidarkish M, Almukhtar M. et al. Global incidence of surgical site infections following caesarean section: a systematic review and meta-analysis. J Hosp Infect 2023; 139: 82-92
    Search in Google Scholar
  • 29 Leth RA, Uldbjerg N, Nørgaard M, Møller JK, Thomsen RW. Obesity, diabetes, and the risk of infections diagnosed in hospital and post-discharge infections after cesarean section: a prospective cohort study. Acta Obstet Gynecol Scand 2011; 90 (05) 501-509
    Search in Google Scholar
  • 30 Wloch C, Wilson J, Lamagni T, Harrington P, Charlett A, Sheridan E. Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG 2012; 119 (11) 1324-1333
    Search in Google Scholar
  • 31 Johanna QN, Gomez J, Felder L. et al. Stepwise implementation of vaginal cleansing and azithromycin at cesarean: a quality improvement study. J Matern Fetal Neonatal Med 2022; 35 (25) 5346-5353
    Search in Google Scholar
  • 32 Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 199: use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2018; 132 (03) e103-e119
    Search in Google Scholar
  • 33 Tita ATN, Rouse DJ, Blackwell S, Saade GR, Spong CY, Andrews WW. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol 2009; 113 (03) 675-682
    Search in Google Scholar
  • 34 Williams JD. Spectrum of activity of azithromycin. Eur J Clin Microbiol Infect Dis 1991; 10 (10) 813-820
    Search in Google Scholar
  • 35 Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 2010; 50 (Suppl. 01) S16-S23
    Search in Google Scholar
  • 36 Schweizer W, Striffeler H, Lüdi D, Fröscher R. “Single-shot”-prophylaxe in der abdominalchirurgie. antibiotika mit langer halbwertzeit (ceftriaxon, ornidazol) vs. antibiotika mit kurzer halbwertzeit (cefazolin, metronidazol, clindamycin). Helv Chir Acta 1994; 60 (04) 483-488 German
    Search in Google Scholar
  • 37 Calfee DP, Grünebaum A. Postoperative antimicrobial prophylaxis following cesarean delivery in obese women: an exception to the rule?. JAMA 2017; 318 (11) 1012-1013
    Search in Google Scholar